Stocks
Revolution Medicines, Inc.RVMD
NASDAQHealthcareBiotechnology$187.19
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing targeted therapies for RAS-driven cancers, a key area in oncology due to the prevalence of RAS mutations. Its lead programs target KRAS mutations, and investors track it for its potential to address a historically undruggable target class.
52W Range: $52.48-$224.31
Congressional Interest in Revolution Medicines, Inc. (RVMD)
No congressional trades have been disclosed for Revolution Medicines, Inc. (RVMD) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading RVMD?
No congressional trades found for this stock.